Literature DB >> 15219854

N-terminal processing and modifications of caveolin-1 in caveolae from human adipocytes.

Julia P Vainonen1, Nabila Aboulaich, Maria V Turkina, Peter Strålfors, Alexander V Vener.   

Abstract

Caveolin, the principal structural protein of caveolae membrane domains, has a cytosol-exposed N-terminal part that was cleaved off by trypsin treatment of caveolae vesicles isolated from primary human adipocytes. Sequencing of the released tryptic peptides by nanospray quadrupole time-of-flight mass spectrometry revealed that both caveolin-1alpha and caveolin-1beta were processed by excision of the starting methionines. The N-terminus of the mature caveolin-1alpha was acetylated, while caveolin-1beta was found in acetylated as well as in non-acetylated forms. Fractional phosphorylation of serine-36 in the mature caveolin-1alpha and of the homologous serine-5 in caveolin-1beta was identified. This is the first experimental evidence for in vivo phosphorylation of caveolin-1 at the consensus site for phosphorylation by protein kinase C. The phosphorylation was found in both the acetylated and non-acetylated variants of caveolin-1beta. This variability in modifications is consistent with critical involvement of the N-terminal domain of caveolin in the regulation of caveolae.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219854     DOI: 10.1016/j.bbrc.2004.05.196

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes.

Authors:  Nabila Aboulaich; Julia P Vainonen; Peter Strålfors; Alexander V Vener
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

Review 2.  Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease.

Authors:  Shilu Luo; Ming Yang; Hao Zhao; Yachun Han; Na Jiang; Jinfei Yang; Wei Chen; Chenrui Li; Yan Liu; Chanyue Zhao; Lin Sun
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.